Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Medullary × Octreotide × Clear all

Sponsor

Conditions

Neuroendocrine Tumors 6 Neoplasms 4 Carcinoid Tumor 4 Carcinoma 3 Vipoma 2 Neoplasm Metastasis 2 Intestinal Obstruction 2 Carcinoma, Islet Cell 2 Somatostatinoma 1 Recurrence 1 Prostatic Neoplasms 1 Primary Inoperable Thymoma 1 Pleural Effusion 1 Peritoneal Neoplasms 1 Malignant Carcinoid Syndrome 1 Lymphangiomyoma 1 Lymphangioleiomyomatosis 1 Insulinoma 1 Glucagonoma 1 Gastro-enteropancreatic neuroendocrine tumor 1 Gastrinoma 1 Diarrhea 1 Chylous Ascites 1 Chylothorax 1 Carcinoma, Neuroendocrine 1 Breast Neoplasms 1 Ascites 1 Adenoma, Islet Cell 1

Interventions

vandetanib 9 cabozantinib 4 selpercatinib 3 Sunitinib 2 Sorafenib 2 yeast-CEA vaccine 1 tanespimycin 1 pralsetinib 1 pembrolizumab 1 pazopanib 1 lenvatinib 1 Vorinostat 1 Temozolomide 1 Pharmacogenomic Testing 1 Magnetic Resonance Spectroscopy 1 Lithium Carbonate 1 Irinotecan 1 Gefitinib 1 Ferrosoferric Oxide 1 Capecitabine 1 Bortezomib 1 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡